Pricing

Log inSign up

Ambagon Therapeutics

0 followers

‌

Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.

Industries

Analytics, Biotechnology

Headquarters

San Francisco, United States

Employees

11-50

Links

Org chart

Willem van den Hout
Research Associate, Biochemistry
Rens de Vries
Scientist, Structural Biology
ES
Eline Sijbesma
Scientist
Laura Demmers
Senior Scientist
Tom van de Wijngaart
Research Associate, Structural Biology
Loes Stevers
Principal Scientist Biochemistry
Donna Olivia Debets
Senior Scientist Proteomics
Taggra Jackson
Sr. Research Associate
Tanja Meyer
VP & Head, Corporate Strategy & Business Development

Board & advisors

Michelle Arkin
Director
Peter Dudek
Director
JN
Janwillem Naesens
Director
MC
Margarita Chavez
Director
AA
Alan Ashworth
Scientific Advisor
CB
Carolyn Bertozzi
Scientific Advisor
Luc Brunsveld
Scientific Advisor
SD
Steve Davidsen
Scientific Advisor
GH
Geraldine Harriman
Scientific Advisor
AT
Ali Tavassoli
Scientific Advisor

Teams

+5

Scientific Research Team

9 people · 0 jobs

JN
+1

Directors Team

5 people · 0 jobs

AA
CB
GH
+3

Scientific Advisory Team

7 people · 0 jobs

Leadership Team

1 person · 0 jobs

Offices

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Latent AI

2 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Cytiva

14 followers

Explore companies